Heat Biologics stock soars 9% on supply contract with Canada for anthrax drug Anthim

Stock Information for null

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About null

Scorpius Holdings Announces Corporate Update Including Cost Optimization Initiatives, Strategic Corporate Developments, and Potential Opportunities for Expansion into Southeast Asia
Scorpius Holdings Provides 2024 Year-End Business Update; Implements Strategic Cost Reductions and Operational Streamlining
Scorpius Holdings Receives NYSE American Notice of Delisting and Reports Plans to Appeal
Scorpius Holdings Engages Alliance Global Partners to Explore Strategic Alternatives
Scorpius Holdings Announces Collaboration with KaloCyte to Advance Manufacturing for ErythroMer(TM)
Scorpius Holdings Announces Reverse Stock Split
Scorpius Holdings Launches Scorpius Ventures to Support U.S. Biotech Innovation through Flexible Equity-Based Onshoring Model
Scorpius Holdings Reports Third Quarter 2024 Results, Highlighting Strategic Partnerships, Cost Savings, and Progress Toward Profitability

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.